Clinical Trial Update: Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

The update reports the completion of a Phase 1/2 study evaluating the combination of pemetrexed with cetuximab in patients with recurrent non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• ERBITUX (cetuximab)

Snippet

Sponsor: Nasser Hanna, M.D. | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-06-02